Agonistic and antagonistic activities of chemokines

Since the discovery of interleukin‐8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of leukocyte biology 2001-06, Vol.69 (6), p.881-884
Hauptverfasser: Loetscher, Pius, Clark‐Lewis, Ian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 884
container_issue 6
container_start_page 881
container_title Journal of leukocyte biology
container_volume 69
creator Loetscher, Pius
Clark‐Lewis, Ian
description Since the discovery of interleukin‐8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic and homing of leukocyte—lymphocytes in particular. All chemokines act via seven‐transmembrane domain, G protein‐coupled receptors. Eighteen such receptors have been identified so far. Studies on structure‐activity relationships indicate that chemokines have two main sites of interaction with their receptors, the flexible NH2‐terminal region and the conformationally rigid loop that follows the second cysteine. Chemokines are thought to dock onto receptors by means of the loop region, and this contact is believed to facilitate the binding of the NH2‐terminal region that results in receptor activation. These studies have also highlighted the importance of the NH2‐terminal region for agonistic and antagonistic activity. Recently, we have shown that some naturally occurring chemokines can function as receptor antagonists. These observations suggest a new mechanism for the regulation of leukocyte recruitment during inflammatory and immune reactions, which are based on the combination of agonistic and antagonistic effects.
doi_str_mv 10.1189/jlb.69.6.881
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17908109</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17908109</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3971-8d5d823d95e3241c0bd858e39f57f3c5e9772e363d801e90e2dcf7372542a6c73</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqWwMaMuMJHgsxN_jKXiU5VYYLZS-9K6JE2JU6L-e4JS0Y3hdNLpufeVHkIugcYASt-tinksdCxipeCIDEFzFXEh-TEZUplAlCaUDshZCCtKKWeCnpIBQEITLmFI-GRRrX1ovB1na9dNkx0OtvHfvvEYxlU-tkssq0-_xnBOTvKsCHix3yPy8fjwPn2OZm9PL9PJLLJcS4iUS51i3OkUOUvA0rlTqUKu81Tm3KaopWTIBXeKAmqKzNlccsnShGXCSj4iN33upq6-thgaU_pgsSiyNVbbYEBqqoDqDrztQVtXIdSYm03ty6zeGaDmV5LpJBmhjTCdpA6_2udu5yW6A7y30gHQA60vcPdvmHmd3dM-9Lr_WfrFsvU1mlBmRdFVMNO27V_5D7szfgU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17908109</pqid></control><display><type>article</type><title>Agonistic and antagonistic activities of chemokines</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Loetscher, Pius ; Clark‐Lewis, Ian</creator><creatorcontrib>Loetscher, Pius ; Clark‐Lewis, Ian</creatorcontrib><description>Since the discovery of interleukin‐8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic and homing of leukocyte—lymphocytes in particular. All chemokines act via seven‐transmembrane domain, G protein‐coupled receptors. Eighteen such receptors have been identified so far. Studies on structure‐activity relationships indicate that chemokines have two main sites of interaction with their receptors, the flexible NH2‐terminal region and the conformationally rigid loop that follows the second cysteine. Chemokines are thought to dock onto receptors by means of the loop region, and this contact is believed to facilitate the binding of the NH2‐terminal region that results in receptor activation. These studies have also highlighted the importance of the NH2‐terminal region for agonistic and antagonistic activity. Recently, we have shown that some naturally occurring chemokines can function as receptor antagonists. These observations suggest a new mechanism for the regulation of leukocyte recruitment during inflammatory and immune reactions, which are based on the combination of agonistic and antagonistic effects.</description><identifier>ISSN: 0741-5400</identifier><identifier>EISSN: 1938-3673</identifier><identifier>DOI: 10.1189/jlb.69.6.881</identifier><identifier>PMID: 11404371</identifier><language>eng</language><publisher>United States: Society for Leukocyte Biology</publisher><subject>Amino Acid Motifs ; chemokine receptors ; Chemokines - chemistry ; Chemokines - pharmacology ; Chemokines - physiology ; chemotaxis ; Chemotaxis, Leukocyte - drug effects ; Chemotaxis, Leukocyte - physiology ; GTP-Binding Proteins - physiology ; guanine nucleotide-binding protein ; Humans ; inflammation ; Leukocytes - cytology ; Leukocytes - drug effects ; Models, Biological ; natural antagonists ; Protein Binding ; Protein Structure, Tertiary ; Receptors, Chemokine - agonists ; Receptors, Chemokine - antagonists &amp; inhibitors ; Receptors, Chemokine - chemistry ; Receptors, Chemokine - physiology ; Structure-Activity Relationship</subject><ispartof>Journal of leukocyte biology, 2001-06, Vol.69 (6), p.881-884</ispartof><rights>2001 Society for Leukocyte Biology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3971-8d5d823d95e3241c0bd858e39f57f3c5e9772e363d801e90e2dcf7372542a6c73</citedby><cites>FETCH-LOGICAL-c3971-8d5d823d95e3241c0bd858e39f57f3c5e9772e363d801e90e2dcf7372542a6c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1189%2Fjlb.69.6.881$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1189%2Fjlb.69.6.881$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11404371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Loetscher, Pius</creatorcontrib><creatorcontrib>Clark‐Lewis, Ian</creatorcontrib><title>Agonistic and antagonistic activities of chemokines</title><title>Journal of leukocyte biology</title><addtitle>J Leukoc Biol</addtitle><description>Since the discovery of interleukin‐8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic and homing of leukocyte—lymphocytes in particular. All chemokines act via seven‐transmembrane domain, G protein‐coupled receptors. Eighteen such receptors have been identified so far. Studies on structure‐activity relationships indicate that chemokines have two main sites of interaction with their receptors, the flexible NH2‐terminal region and the conformationally rigid loop that follows the second cysteine. Chemokines are thought to dock onto receptors by means of the loop region, and this contact is believed to facilitate the binding of the NH2‐terminal region that results in receptor activation. These studies have also highlighted the importance of the NH2‐terminal region for agonistic and antagonistic activity. Recently, we have shown that some naturally occurring chemokines can function as receptor antagonists. These observations suggest a new mechanism for the regulation of leukocyte recruitment during inflammatory and immune reactions, which are based on the combination of agonistic and antagonistic effects.</description><subject>Amino Acid Motifs</subject><subject>chemokine receptors</subject><subject>Chemokines - chemistry</subject><subject>Chemokines - pharmacology</subject><subject>Chemokines - physiology</subject><subject>chemotaxis</subject><subject>Chemotaxis, Leukocyte - drug effects</subject><subject>Chemotaxis, Leukocyte - physiology</subject><subject>GTP-Binding Proteins - physiology</subject><subject>guanine nucleotide-binding protein</subject><subject>Humans</subject><subject>inflammation</subject><subject>Leukocytes - cytology</subject><subject>Leukocytes - drug effects</subject><subject>Models, Biological</subject><subject>natural antagonists</subject><subject>Protein Binding</subject><subject>Protein Structure, Tertiary</subject><subject>Receptors, Chemokine - agonists</subject><subject>Receptors, Chemokine - antagonists &amp; inhibitors</subject><subject>Receptors, Chemokine - chemistry</subject><subject>Receptors, Chemokine - physiology</subject><subject>Structure-Activity Relationship</subject><issn>0741-5400</issn><issn>1938-3673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQhi0EoqWwMaMuMJHgsxN_jKXiU5VYYLZS-9K6JE2JU6L-e4JS0Y3hdNLpufeVHkIugcYASt-tinksdCxipeCIDEFzFXEh-TEZUplAlCaUDshZCCtKKWeCnpIBQEITLmFI-GRRrX1ovB1na9dNkx0OtvHfvvEYxlU-tkssq0-_xnBOTvKsCHix3yPy8fjwPn2OZm9PL9PJLLJcS4iUS51i3OkUOUvA0rlTqUKu81Tm3KaopWTIBXeKAmqKzNlccsnShGXCSj4iN33upq6-thgaU_pgsSiyNVbbYEBqqoDqDrztQVtXIdSYm03ty6zeGaDmV5LpJBmhjTCdpA6_2udu5yW6A7y30gHQA60vcPdvmHmd3dM-9Lr_WfrFsvU1mlBmRdFVMNO27V_5D7szfgU</recordid><startdate>200106</startdate><enddate>200106</enddate><creator>Loetscher, Pius</creator><creator>Clark‐Lewis, Ian</creator><general>Society for Leukocyte Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>200106</creationdate><title>Agonistic and antagonistic activities of chemokines</title><author>Loetscher, Pius ; Clark‐Lewis, Ian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3971-8d5d823d95e3241c0bd858e39f57f3c5e9772e363d801e90e2dcf7372542a6c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Amino Acid Motifs</topic><topic>chemokine receptors</topic><topic>Chemokines - chemistry</topic><topic>Chemokines - pharmacology</topic><topic>Chemokines - physiology</topic><topic>chemotaxis</topic><topic>Chemotaxis, Leukocyte - drug effects</topic><topic>Chemotaxis, Leukocyte - physiology</topic><topic>GTP-Binding Proteins - physiology</topic><topic>guanine nucleotide-binding protein</topic><topic>Humans</topic><topic>inflammation</topic><topic>Leukocytes - cytology</topic><topic>Leukocytes - drug effects</topic><topic>Models, Biological</topic><topic>natural antagonists</topic><topic>Protein Binding</topic><topic>Protein Structure, Tertiary</topic><topic>Receptors, Chemokine - agonists</topic><topic>Receptors, Chemokine - antagonists &amp; inhibitors</topic><topic>Receptors, Chemokine - chemistry</topic><topic>Receptors, Chemokine - physiology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Loetscher, Pius</creatorcontrib><creatorcontrib>Clark‐Lewis, Ian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of leukocyte biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Loetscher, Pius</au><au>Clark‐Lewis, Ian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Agonistic and antagonistic activities of chemokines</atitle><jtitle>Journal of leukocyte biology</jtitle><addtitle>J Leukoc Biol</addtitle><date>2001-06</date><risdate>2001</risdate><volume>69</volume><issue>6</issue><spage>881</spage><epage>884</epage><pages>881-884</pages><issn>0741-5400</issn><eissn>1938-3673</eissn><abstract>Since the discovery of interleukin‐8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic and homing of leukocyte—lymphocytes in particular. All chemokines act via seven‐transmembrane domain, G protein‐coupled receptors. Eighteen such receptors have been identified so far. Studies on structure‐activity relationships indicate that chemokines have two main sites of interaction with their receptors, the flexible NH2‐terminal region and the conformationally rigid loop that follows the second cysteine. Chemokines are thought to dock onto receptors by means of the loop region, and this contact is believed to facilitate the binding of the NH2‐terminal region that results in receptor activation. These studies have also highlighted the importance of the NH2‐terminal region for agonistic and antagonistic activity. Recently, we have shown that some naturally occurring chemokines can function as receptor antagonists. These observations suggest a new mechanism for the regulation of leukocyte recruitment during inflammatory and immune reactions, which are based on the combination of agonistic and antagonistic effects.</abstract><cop>United States</cop><pub>Society for Leukocyte Biology</pub><pmid>11404371</pmid><doi>10.1189/jlb.69.6.881</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5400
ispartof Journal of leukocyte biology, 2001-06, Vol.69 (6), p.881-884
issn 0741-5400
1938-3673
language eng
recordid cdi_proquest_miscellaneous_17908109
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals
subjects Amino Acid Motifs
chemokine receptors
Chemokines - chemistry
Chemokines - pharmacology
Chemokines - physiology
chemotaxis
Chemotaxis, Leukocyte - drug effects
Chemotaxis, Leukocyte - physiology
GTP-Binding Proteins - physiology
guanine nucleotide-binding protein
Humans
inflammation
Leukocytes - cytology
Leukocytes - drug effects
Models, Biological
natural antagonists
Protein Binding
Protein Structure, Tertiary
Receptors, Chemokine - agonists
Receptors, Chemokine - antagonists & inhibitors
Receptors, Chemokine - chemistry
Receptors, Chemokine - physiology
Structure-Activity Relationship
title Agonistic and antagonistic activities of chemokines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T05%3A52%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Agonistic%20and%20antagonistic%20activities%20of%20chemokines&rft.jtitle=Journal%20of%20leukocyte%20biology&rft.au=Loetscher,%20Pius&rft.date=2001-06&rft.volume=69&rft.issue=6&rft.spage=881&rft.epage=884&rft.pages=881-884&rft.issn=0741-5400&rft.eissn=1938-3673&rft_id=info:doi/10.1189/jlb.69.6.881&rft_dat=%3Cproquest_cross%3E17908109%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17908109&rft_id=info:pmid/11404371&rfr_iscdi=true